| Year |
Citation |
Score |
| 2017 |
Turner RC, Naser ZJ, Lucke-Wold BP, Logsdon AF, Vangilder RL, Matsumoto RR, Huber JD, Rosen CL. Single low-dose lipopolysaccharide preconditioning: neuroprotective against axonal injury and modulates glial cells. Neuroimmunology and Neuroinflammation. 4: 6-15. PMID 28164149 DOI: 10.20517/2347-8659.2016.40 |
0.545 |
|
| 2015 |
Barr TL, VanGilder R, Rellick S, Brooks SD, Doll DN, Lucke-Wold AN, Chen D, Denvir J, Warach S, Singleton A, Matarin M. A genomic profile of the immune response to stroke with implications for stroke recovery. Biological Research For Nursing. 17: 248-56. PMID 25124890 DOI: 10.1177/1099800414546492 |
0.336 |
|
| 2014 |
VanGilder RL, Huber JD. Sesamol: a Treatment for Diabetes-Associated Blood-Brain Barrier Dysfunction. Postdoc Journal : a Journal of Postdoctoral Research and Postdoctoral Affairs. 2: 13-22. PMID 28781979 DOI: 10.14304/Surya.Jpr.V2N7.2 |
0.591 |
|
| 2014 |
Turner RC, VanGilder RL, Naser ZJ, Lucke-Wold BP, Bailes JE, Matsumoto RR, Huber JD, Rosen CL. Elucidating the severity of preclinical traumatic brain injury models: a role for functional assessment? Neurosurgery. 74: 382-94; discussion 3. PMID 24448183 DOI: 10.1227/Neu.0000000000000292 |
0.568 |
|
| 2014 |
VanGilder RL, Davidov DM, Stinehart KR, Huber JD, Turner RC, Wilson KS, Haney E, Davis SM, Chantler PD, Theeke L, Rosen CL, Crocco TJ, Gutmann L, Barr TL. C-reactive protein and long-term ischemic stroke prognosis. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. 21: 547-53. PMID 24211144 DOI: 10.1016/J.Jocn.2013.06.015 |
0.56 |
|
| 2012 |
VanGilder RL, Huber JD, Rosen CL, Barr TL. The transcriptome of cerebral ischemia. Brain Research Bulletin. 88: 313-9. PMID 22381515 DOI: 10.1016/J.Brainresbull.2012.02.002 |
0.576 |
|
| 2011 |
Vangilder RL, Rosen CL, Barr TL, Huber JD. Targeting the neurovascular unit for treatment of neurological disorders. Pharmacology & Therapeutics. 130: 239-47. PMID 21172386 DOI: 10.1016/J.Pharmthera.2010.12.004 |
0.538 |
|
| 2009 |
Kelly KA, Li X, Tan Z, VanGilder RL, Rosen CL, Huber JD. NOX2 inhibition with apocynin worsens stroke outcome in aged rats. Brain Research. 1292: 165-72. PMID 19635468 DOI: 10.1016/J.Brainres.2009.07.052 |
0.604 |
|
| 2009 |
VanGilder RL, Kelly KA, Chua MD, Ptachcinski RL, Huber JD. Administration of sesamol improved blood-brain barrier function in streptozotocin-induced diabetic rats. Experimental Brain Research. 197: 23-34. PMID 19565232 DOI: 10.1007/S00221-009-1866-6 |
0.587 |
|
| 2006 |
Huber JD, VanGilder RL, Houser KA. Streptozotocin-induced diabetes progressively increases blood-brain barrier permeability in specific brain regions in rats. American Journal of Physiology. Heart and Circulatory Physiology. 291: H2660-8. PMID 16951046 DOI: 10.1152/Ajpheart.00489.2006 |
0.607 |
|
| Show low-probability matches. |